Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00548132 · ClinicalTrials.gov registry record · Phase 4
Reducing Catheter-Related Bloodstream Infections in the ICU With a Chlorhexidine-Impregnated Sponge (BIOPATCH)
A Phase 4 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,088
- Enrollment target
NCT00548132 is a Phase 4 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,088 participants.
The verdict
NCT00548132, a Phase 4 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,088 participants
- Enrollment target
Study Summary
We proposed to perform a prospective randomized controlled trial to study the effect of the use of a commercially-available chlorhexidine-impregnated sponge (Biopatch) as part of central venous catheter care on catheter-related bloodstream infections among patients in two Barnes-Jewish Hospital ICUs.
Interventions
- DEVICE Chlorhexidine-impregnated foam dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,088 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00548132
The ClinicalTrials.gov registry entry for NCT00548132 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,088 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chlorhexidine-impregnated foam dressing is the first listed.
NCT00548132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00548132 about?
NCT00548132 is a clinical study titled "Reducing Catheter-Related Bloodstream Infections in the ICU With a Chlorhexidine-Impregnated Sponge (BIOPATCH)". We proposed to perform a prospective randomized controlled trial to study the effect of the use of a commercially-available chlorhexidine-impregnated sponge (Biopatch) as part of central venous catheter care on catheter-related bloodstream infections among patients in two Barnes-Jewish Hospital ICUs...
What is the current status of trial NCT00548132?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,088 participants. The study started on 2006-02. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00548132?
The interventions under investigation include: Chlorhexidine-impregnated foam dressing (DEVICE).
Who is sponsoring clinical trial NCT00548132?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.